221 related articles for article (PubMed ID: 37999140)
21. Microarray profiles of human basal cell carcinoma: insights into tumor growth and behavior.
Howell BG; Solish N; Lu C; Watanabe H; Mamelak AJ; Freed I; Wang B; Sauder DN
J Dermatol Sci; 2005 Jul; 39(1):39-51. PubMed ID: 15978418
[TBL] [Abstract][Full Text] [Related]
22. Newer variants and simulants of basal cell carcinoma.
Lowe L; Rapini RP
J Dermatol Surg Oncol; 1991 Aug; 17(8):641-8. PubMed ID: 1885825
[TBL] [Abstract][Full Text] [Related]
23. A Clinical Study of Basal Cell Carcinoma.
Kasumagic-Halilovic E; Hasic M; Ovcina-Kurtovic N
Med Arch; 2019 Dec; 73(6):394-398. PubMed ID: 32082007
[TBL] [Abstract][Full Text] [Related]
24. Variations in clinical presentation of basal cell carcinoma.
Buljan M; Bulat V; Situm M; Mihić LL; Stanić-Duktaj S
Acta Clin Croat; 2008 Mar; 47(1):25-30. PubMed ID: 18714644
[TBL] [Abstract][Full Text] [Related]
25. Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma.
Abbas O; Richards JE; Mahalingam M
Mod Pathol; 2010 Nov; 23(11):1535-43. PubMed ID: 20711172
[TBL] [Abstract][Full Text] [Related]
26. Skin cancers and their etiologies.
Marghoob AA
Semin Cutan Med Surg; 2011 Dec; 30(4 Suppl):S1-5. PubMed ID: 22177100
[TBL] [Abstract][Full Text] [Related]
27. Pigmented Basal Cell Carcinoma: An Argument for Sub-Classification.
Saizan A; Taylor S; Elbuluk N
J Drugs Dermatol; 2023 Feb; 22(2):217-218. PubMed ID: 36745362
[TBL] [Abstract][Full Text] [Related]
28. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
29. Management of periorbital basal cell carcinoma with orbital invasion.
Sun MT; Wu A; Figueira E; Huilgol S; Selva D
Future Oncol; 2015 Nov; 11(22):3003-10. PubMed ID: 26437207
[TBL] [Abstract][Full Text] [Related]
30. Dermoscopic criteria and basal cell carcinoma.
Del Busto-Wilhelm I; Malvehy J; Puig S
G Ital Dermatol Venereol; 2016 Dec; 151(6):642-648. PubMed ID: 27356243
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of programmed cell death ligand 1 (PD-L1) and inflammatory cells in basal cell carcinoma subtypes.
Gompertz-Mattar M; Perales J; Sahu A; Mondaca S; Gonzalez S; Uribe P; Navarrete-Dechent C
Arch Dermatol Res; 2022 Oct; 314(8):777-786. PubMed ID: 34647186
[TBL] [Abstract][Full Text] [Related]
32. New concepts for basal cell carcinoma. Demographic, clinical, histological risk factors, and biomarkers. A systematic review of evidence regarding risk for tumor development, susceptibility for second primary and recurrence.
Kyrgidis A; Tzellos TG; Vahtsevanos K; Triaridis S
J Surg Res; 2010 Mar; 159(1):545-56. PubMed ID: 19285687
[TBL] [Abstract][Full Text] [Related]
33. Fatal outcome in a metatypical, giant, "horrifying" basal cell carcinoma.
Bianchini R; Wolter M
J Dermatol Surg Oncol; 1987 May; 13(5):556-7. PubMed ID: 3571694
[TBL] [Abstract][Full Text] [Related]
34. Identifying patients at risk for recurrent or advanced BCC.
Hamid O; Goldenberg G
J Drugs Dermatol; 2013 Nov; 12(11):1246-52; quiz 1253-4. PubMed ID: 24196332
[TBL] [Abstract][Full Text] [Related]
35. The significance of mast cells associated with basal cell carcinoma.
Erkiliç S; Erbağci Z
J Dermatol; 2001 Jun; 28(6):312-5. PubMed ID: 11476109
[TBL] [Abstract][Full Text] [Related]
36. Dermoscopic features of basal cell carcinoma and its subtypes: A systematic review.
Reiter O; Mimouni I; Dusza S; Halpern AC; Leshem YA; Marghoob AA
J Am Acad Dermatol; 2021 Sep; 85(3):653-664. PubMed ID: 31706938
[TBL] [Abstract][Full Text] [Related]
37. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
38. Adenoid basal cell carcinoma: a rare facet of basal cell carcinoma.
Saxena K; Manohar V; Bhakhar V; Bahl S
BMJ Case Rep; 2016 Apr; 2016():10.1136/bcr-2015-214166. PubMed ID: 27095806
[TBL] [Abstract][Full Text] [Related]
39. Basal cell carcinoma progression correlates with host immune response and stromal alterations: a histologic analysis.
Kaur P; Mulvaney M; Carlson JA
Am J Dermatopathol; 2006 Aug; 28(4):293-307. PubMed ID: 16871032
[TBL] [Abstract][Full Text] [Related]
40. Surgical analysis and biological behaviour of 2277 basal cell carcinomas.
Emmett AJ
Aust N Z J Surg; 1990 Nov; 60(11):855-63. PubMed ID: 2241644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
